GE HEALTHCARE TECHNOLOGY (GEHC)
US36266G1076 - Common Stock
Taking everything into account, GEHC scores 5 out of 10 in our fundamental rating. GEHC was compared to 187 industry peers in the Health Care Equipment & Supplies industry. GEHC scores excellent on profitability, but there are concerns on its financial health. GEHC is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
GEHC had positive earnings in the past year.
In the past year GEHC had a positive cash flow from operations.
Each year in the past 5 years GEHC has been profitable.
In the past 5 years GEHC always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of GEHC (4.95%) is better than 84.41% of its industry peers.
With an excellent Return On Equity value of 20.14%, GEHC belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
GEHC has a Return On Invested Capital of 7.29%. This is amongst the best in the industry. GEHC outperforms 85.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 8.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 20.14% | ||
| ROIC | 7.29% |
ROA(3y)6.59%
ROA(5y)N/A
ROE(3y)17.8%
ROE(5y)N/A
ROIC(3y)9.03%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 8.56%, GEHC belongs to the best of the industry, outperforming 81.18% of the companies in the same industry.
In the last couple of years the Profit Margin of GEHC has declined.
With an excellent Operating Margin value of 12.85%, GEHC belongs to the best of the industry, outperforming 81.72% of the companies in the same industry.
In the last couple of years the Operating Margin of GEHC has declined.
Looking at the Gross Margin, with a value of 41.33%, GEHC is doing worse than 67.74% of the companies in the same industry.
In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.85% | ||
| PM (TTM) | 8.56% | ||
| GM | 41.33% |
OM growth 3Y-7.72%
OM growth 5YN/A
PM growth 3Y-55.55%
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5YN/A
2. Health
2.1 Basic Checks
GEHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
GEHC has more shares outstanding than it did 1 year ago.
The debt/assets ratio for GEHC has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.84 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
GEHC's Altman-Z score of 1.84 is in line compared to the rest of the industry. GEHC outperforms 59.14% of its industry peers.
GEHC has a debt to FCF ratio of 6.08. This is a slightly negative value and a sign of low solvency as GEHC would need 6.08 years to pay back of all of its debts.
The Debt to FCF ratio of GEHC (6.08) is better than 75.81% of its industry peers.
GEHC has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of GEHC (1.12) is worse than 77.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.12 | ||
| Debt/FCF | 6.08 | ||
| Altman-Z | 1.84 |
ROIC/WACC0.83
WACC8.83%
2.3 Liquidity
GEHC has a Current Ratio of 1.23. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
GEHC has a worse Current ratio (1.23) than 85.48% of its industry peers.
A Quick Ratio of 0.98 indicates that GEHC may have some problems paying its short term obligations.
GEHC's Quick ratio of 0.98 is on the low side compared to the rest of the industry. GEHC is outperformed by 80.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.69% over the past year.
Measured over the past years, GEHC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -53.65% on average per year.
Looking at the last year, GEHC shows a small growth in Revenue. The Revenue has grown by 1.42% in the last year.
Measured over the past years, GEHC shows a small growth in Revenue. The Revenue has been growing by 4.44% on average per year.
EPS 1Y (TTM)3.69%
EPS 3Y-53.65%
EPS 5YN/A
EPS Q2Q%15.15%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y4.44%
Revenue growth 5YN/A
Sales Q2Q%0.85%
3.2 Future
GEHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.78% yearly.
GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y11.13%
EPS Next 2Y9.87%
EPS Next 3Y10.35%
EPS Next 5Y9.78%
Revenue Next Year1.35%
Revenue Next 2Y2.68%
Revenue Next 3Y3.23%
Revenue Next 5Y3.86%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.53, which indicates a rather expensive current valuation of GEHC.
Based on the Price/Earnings ratio, GEHC is valued cheaper than 88.17% of the companies in the same industry.
GEHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.17.
Based on the Price/Forward Earnings ratio of 16.44, the valuation of GEHC can be described as correct.
88.17% of the companies in the same industry are more expensive than GEHC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.59. GEHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.53 | ||
| Fwd PE | 16.44 |
4.2 Price Multiples
86.56% of the companies in the same industry are more expensive than GEHC, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 89.25% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.07 | ||
| EV/EBITDA | 13.71 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.66
PEG (5Y)N/A
EPS Next 2Y9.87%
EPS Next 3Y10.35%
5. Dividend
5.1 Amount
GEHC has a yearly dividend return of 0.18%, which is pretty low.
GEHC's Dividend Yield is rather good when compared to the industry average which is at 1.65. GEHC pays more dividend than 90.32% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, GEHC's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
5.2 History
GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
GEHC pays out 3.22% of its income as dividend. This is a sustainable payout ratio.
DP3.22%
EPS Next 2Y9.87%
EPS Next 3Y10.35%
GE HEALTHCARE TECHNOLOGY
NASDAQ:GEHC (12/31/2024, 8:00:00 PM)
Premarket: 78.18 0 (0%)78.18
-0.42 (-0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners78.8%
Inst Owner Change1.56%
Ins Owners0.17%
Ins Owner Change-0.95%
Market Cap35.72B
Analysts77.6
Price Target98.96 (26.58%)
Short Float %2.09%
Short Ratio2.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
Dividend Growth(5Y)N/A
DP3.22%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.17%
Min EPS beat(2)0.18%
Max EPS beat(2)6.17%
EPS beat(4)3
Avg EPS beat(4)2.94%
Min EPS beat(4)-2.68%
Max EPS beat(4)8.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-2.64%
Max Revenue beat(2)-2.07%
Revenue beat(4)1
Avg Revenue beat(4)-2.38%
Min Revenue beat(4)-5.04%
Max Revenue beat(4)0.25%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)1.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.76%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)1.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.64%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.53 | ||
| Fwd PE | 16.44 | ||
| P/S | 1.83 | ||
| P/FCF | 21.07 | ||
| P/OCF | 17.11 | ||
| P/B | 4.29 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.71 |
EPS(TTM)4.22
EY5.4%
EPS(NY)4.76
Fwd EY6.08%
FCF(TTM)3.71
FCFY4.75%
OCF(TTM)4.57
OCFY5.85%
SpS42.81
BVpS18.2
TBVpS-13.03
PEG (NY)1.66
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 20.14% | ||
| ROCE | 9.98% | ||
| ROIC | 7.29% | ||
| ROICexc | 8.49% | ||
| ROICexgc | 24.99% | ||
| OM | 12.85% | ||
| PM (TTM) | 8.56% | ||
| GM | 41.33% | ||
| FCFM | 8.67% |
ROA(3y)6.59%
ROA(5y)N/A
ROE(3y)17.8%
ROE(5y)N/A
ROIC(3y)9.03%
ROIC(5y)N/A
ROICexc(3y)9.66%
ROICexc(5y)N/A
ROICexgc(3y)38.17%
ROICexgc(5y)N/A
ROCE(3y)12.36%
ROCE(5y)N/A
ROICexcg growth 3Y-24.76%
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.67%
ROICexc growth 5YN/A
OM growth 3Y-7.72%
OM growth 5YN/A
PM growth 3Y-55.55%
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.12 | ||
| Debt/FCF | 6.08 | ||
| Debt/EBITDA | 3 | ||
| Cap/Depr | 67.29% | ||
| Cap/Sales | 2.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.42% | ||
| Profit Quality | 101.19% | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 1.84 |
F-Score6
WACC8.83%
ROIC/WACC0.83
Cap/Depr(3y)50.7%
Cap/Depr(5y)48.69%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.72%
Profit Quality(3y)92.78%
Profit Quality(5y)78.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.69%
EPS 3Y-53.65%
EPS 5YN/A
EPS Q2Q%15.15%
EPS Next Y11.13%
EPS Next 2Y9.87%
EPS Next 3Y10.35%
EPS Next 5Y9.78%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y4.44%
Revenue growth 5YN/A
Sales Q2Q%0.85%
Revenue Next Year1.35%
Revenue Next 2Y2.68%
Revenue Next 3Y3.23%
Revenue Next 5Y3.86%
EBIT growth 1Y-0.4%
EBIT growth 3Y-3.62%
EBIT growth 5YN/A
EBIT Next Year26.73%
EBIT Next 3Y13.03%
EBIT Next 5Y9.51%
FCF growth 1Y124.8%
FCF growth 3Y-10.1%
FCF growth 5YN/A
OCF growth 1Y96.98%
OCF growth 3Y-7.07%
OCF growth 5YN/A